Search Results

There are 63055 results for: content related to: Modification of risk for cancer as a coincidental finding in DNA array investigation

  1. Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation

    Pathology International

    Volume 61, Issue 6, June 2011, Pages: 331–344, Yoshitaka Sekido

    Version of Record online : 2 MAY 2011, DOI: 10.1111/j.1440-1827.2011.02666.x

  2. CpG island hypermethylation of the neurofibromatosis type 2 (NF2) gene is rare in sporadic vestibular schwannomas

    Neuropathology and Applied Neurobiology

    Volume 36, Issue 6, October 2010, Pages: 505–514, P. J. Kullar, D. M. Pearson, D. S. Malley, V. P. Collins and K. Ichimura

    Version of Record online : 14 MAY 2010, DOI: 10.1111/j.1365-2990.2010.01090.x

  3. Genetic testing and screening of individuals at risk of NF2

    Clinical Genetics

    Volume 82, Issue 5, November 2012, Pages: 416–424, DG Evans, FL Raymond, JG Barwell and D Halliday

    Version of Record online : 16 DEC 2011, DOI: 10.1111/j.1399-0004.2011.01816.x

  4. You have free access to this content
    Regulation of the Neurofibromatosis 2 gene promoter expression during embryonic development

    Developmental Dynamics

    Volume 235, Issue 10, October 2006, Pages: 2771–2785, Elena M. Akhmametyeva, Maria M. Mihaylova, Huijun Luo, Sadeq Kharzai, D. Bradley Welling and Long-Sheng Chang

    Version of Record online : 7 AUG 2006, DOI: 10.1002/dvdy.20883

  5. Cdc42 regulates schwann cell radial sorting and myelin sheath folding through NF2/merlin-dependent and independent signaling

    Glia

    Volume 61, Issue 11, November 2013, Pages: 1906–1921, Li Guo, Chandra Moon, Yi Zheng and Nancy Ratner

    Version of Record online : 6 SEP 2013, DOI: 10.1002/glia.22567

  6. You have free access to this content
    Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2

    American Journal of Medical Genetics Part A

    Volume 158A, Issue 1, January 2012, Pages: 24–41, Jaishri O. Blakeley, D. Gareth Evans, John Adler, Derald Brackmann, Ruihong Chen, Rosalie E. Ferner, C. Oliver Hanemann, Gordon Harris, Susan M. Huson, Abraham Jacob, Michel Kalamarides, Matthias A. Karajannis, Bruce R. Korf, Victor-Felix Mautner, Andrea I. McClatchey, Harry Miao, Scott R. Plotkin, William Slattery III, Anat O. Stemmer-Rachamimov, D. Bradley Welling, Patrick Y. Wen, Brigitte Widemann, Kim Hunter-Schaedle and Marco Giovannini

    Version of Record online : 2 DEC 2011, DOI: 10.1002/ajmg.a.34359

  7. Should NF2 mutation screening be undertaken in patients with an apparently isolated vestibular schwannoma?

    Clinical Genetics

    Volume 71, Issue 4, April 2007, Pages: 354–358, DGR Evans, RT Ramsden, C Gokhale, N Bowers, SM Huson and A Wallace

    Version of Record online : 25 APR 2007, DOI: 10.1111/j.1399-0004.2007.00778.x

  8. Clinical presentation, immunohistochemistry and electron microscopy indicate neurofibromatosis type 2-associated gliomas to be spinal ependymomas

    Neuropathology

    Volume 32, Issue 6, December 2012, Pages: 611–616, Christian Hagel, Anat O. Stemmer-Rachamimov, Antje Bornemann, Martin Schuhmann, Christoph Nagel, Susan Huson, D Gareth Evans, Scott Plotkin, Cordula Matthies, Lan Kluwe and Victor-Felix Mautner

    Version of Record online : 7 MAR 2012, DOI: 10.1111/j.1440-1789.2012.01306.x

  9. Calpain-dependent proteolysis of NF2 protein: Involvement in schwannomas and meningiomas

    Neuropathology

    Volume 20, Issue 3, September 2000, Pages: 153–160, Yoriyoshi Kimura, Hideyuki Saya and Mitsuyoshi Nakao

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1440-1789.2000.00326.x

  10. Clinical Manifestations of Mutations in the Neurofibromatosis Type 2 Gene in Vestibular Schwannomas (Acoustic Neuromas)

    The Laryngoscope

    Volume 108, Issue 2, February 1998, Pages: 178–189, D. Bradley Welling

    Version of Record online : 4 JAN 2009, DOI: 10.1097/00005537-199802000-00005

  11. You have free access to this content
    What's new in neurofibromatosis? Proceedings from the 2009 NF Conference: New Frontiers

    American Journal of Medical Genetics Part A

    Volume 152A, Issue 2, February 2010, Pages: 269–283, Joseph L. Kissil, Jaishri O. Blakeley, Rosalie E. Ferner, Susan M. Huson, Michel Kalamarides, Victor-Felix Mautner, Frank McCormick, Helen Morrison, Roger Packer, Vijaya Ramesh, Nancy Ratner, Katherine A. Rauen, David A. Stevenson, Kim Hunter-Schaedle and Kathryn North

    Version of Record online : 15 JAN 2010, DOI: 10.1002/ajmg.a.33189

  12. Determination of the mutant allele frequency in patients with neurofibromatosis type 2 and somatic mosaicism by means of deep sequencing

    Genes, Chromosomes and Cancer

    Volume 54, Issue 8, August 2015, Pages: 482–488, Melanie Spyra, Benjamin Otto, Gerhard Schön, Hildegard Kehrer-Sawatzki and Victor-Felix Mautner

    Version of Record online : 29 MAY 2015, DOI: 10.1002/gcc.22259

  13. The role and regulatory mechanism of IL-1β on the methylation of the NF2 gene in benign meningiomas and leptomeninges

    Molecular Carcinogenesis

    Volume 55, Issue 12, December 2016, Pages: 2268–2277, Baofeng Wang, Zhenwen Cui, Zhihong Zhong, Yuhao Sun, Guo-Yuan Yang, Qingfang Sun and Liuguan Bian

    Version of Record online : 3 FEB 2016, DOI: 10.1002/mc.22467

  14. Neurofibromatosis 2 with peripheral neuropathies: Electrophysiological, pathological and genetic studies of a Taiwanese family

    Neuropathology

    Volume 30, Issue 5, October 2010, Pages: 515–523, Hung-Chou Kuo, Shyue-Ru Chen, Shih-Ming Jung, Yah-Huei Wu Chou, Chin-Chang Huang, Wen-Li Chuang, Kuo-Chen Wei and Long-Sun Ro

    Version of Record online : 26 JAN 2010, DOI: 10.1111/j.1440-1789.2009.01099.x

  15. NF2: The wizardry of merlin

    Genes, Chromosomes and Cancer

    Volume 38, Issue 4, December 2003, Pages: 389–399, Guang-Hui Xiao, Jonathan Chernoff and Joseph R. Testa

    Version of Record online : 8 OCT 2003, DOI: 10.1002/gcc.10282

  16. You have free access to this content
    Identification of the cis-acting region in the NF2 gene promoter as a potential target for mutation and methylation-dependent silencing in schwannoma

    Genes to Cells

    Volume 6, Issue 5, May 2001, Pages: 441–454, Takeshi Kino, Hideo Takeshima, Mitsuyoshi Nakao, Toru Nishi, Keizo Yamamoto, Takahiro Kimura, Yoshiki Saito, Masato Kochi, Jun-ichi Kuratsu, Hideyuki Saya and Yukitaka Ushio

    Version of Record online : 20 DEC 2001, DOI: 10.1046/j.1365-2443.2001.00432.x

  17. Neurofibromatosis Type 2 Clinics and Genetics

    Standard Article

    eLS

    Lan Kluwe and Victor-F Mautner

    Published Online : 15 SEP 2010, DOI: 10.1002/9780470015902.a0022391

  18. Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas

    Genes, Chromosomes and Cancer

    Volume 42, Issue 3, March 2005, Pages: 314–319, Jesus Lomas, M. Josefa Bello, Dolores Arjona, M. Eva Alonso, Victor Martinez-Glez, Isabel Lopez-Marin, Cinthia Amiñoso, Jose M. de Campos, Alberto Isla, Jesus Vaquero and Juan A. Rey

    Version of Record online : 17 DEC 2004, DOI: 10.1002/gcc.20141

  19. Role of NF2 Haploinsufficiency in NF2-associated Polyneuropathy

    Brain Pathology

    Volume 17, Issue 4, October 2007, Pages: 371–376, Clemens O. Hanemann, Ruth Diebold and Dieter Kaufmann

    Version of Record online : 26 JUL 2007, DOI: 10.1111/j.1750-3639.2007.00086.x

  20. You have free access to this content
    Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus

    EMBO reports

    Volume 13, Issue 3, March 2012, Pages: 204–215, Wei Li, Jonathan Cooper, Matthias A Karajannis and Filippo G Giancotti

    Version of Record online : 21 FEB 2012, DOI: 10.1038/embor.2012.11